Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Rhumbline Advisers

Rhumbline Advisers decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,293,794 shares of the pharmacy operator’s stock after selling 21,627 shares during the period. Rhumbline Advisers owned about 0.15% of Walgreens Boots Alliance worth $12,071,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in WBA. Charles Schwab Investment Management Inc. increased its position in Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Altrius Capital Management Inc boosted its stake in shares of Walgreens Boots Alliance by 76.6% during the 3rd quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock worth $3,947,000 after purchasing an additional 190,996 shares during the last quarter. Swedbank AB grew its holdings in shares of Walgreens Boots Alliance by 45.3% during the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after buying an additional 185,762 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock valued at $3,050,000 after buying an additional 64,586 shares during the last quarter. Finally, Sasco Capital Inc. CT lifted its stake in shares of Walgreens Boots Alliance by 13.6% during the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after buying an additional 124,950 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on WBA shares. Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Truist Financial dropped their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Evercore ISI raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $12.63.

Walgreens Boots Alliance Stock Down 3.3 %

WBA stock opened at $10.16 on Monday. The stock has a market cap of $8.78 billion, a PE ratio of -0.99, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65. The firm’s 50-day simple moving average is $10.37 and its 200 day simple moving average is $9.70. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the company posted $0.66 earnings per share. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.